DMCC Speciality Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 3:28 pm

Market Cap	763 Cr.
Current Price	306
High / Low	453/241
Stock P/E	35.4
Book Value	91.1
Dividend Yield	0.33 %
ROCE	14.6 %
ROE	9.87 %
Face Value	10.0
PEG Ratio	-4.46

Quick Insight

DMCC Speciality Chemicals Ltd, currently priced at ₹313 with a market capitalization of ₹781 crore, exhibits a P/E ratio of 36.3, indicating a premium valuation relative to its earnings potential. The company's return on equity (ROE) stands at 9.87%, while its return on capital employed (ROCE) is a healthier 14.6%, suggesting effective capital utilization. With operating profit margins (OPM) at 12.08% and a net profit of ₹22 crore, the company is generating reasonable returns. Additionally, a robust interest coverage ratio (ICR) of 5.56x and manageable borrowings of ₹47 crore indicate financial stability. However, with promoter ownership at 53.84% and low foreign institutional investment (FIIs) at 0.36%, investor confidence may be a concern. Overall, while DMCC shows potential for growth, the high valuation metrics suggest caution for prospective investors.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for DMCC Speciality Chemicals Ltd

Competitors of DMCC Speciality Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	456 Cr.	49.7	104/42.6	25.6	20.0	0.60 %	13.9 %	10.1 %	2.00
Haryana Leather Chemicals Ltd	33.4 Cr.	68.1	124/62.6	14.9	87.4	1.47 %	8.04 %	5.47 %	10.0
Hardcastle & Waud Mfg Co Ltd	51.0 Cr.	749	1,178/600	39.5	670	0.00 %	6.20 %	2.87 %	10.0
Grauer & Weil (India) Ltd	4,391 Cr.	96.8	120/78.0	28.6	20.7	0.52 %	23.3 %	17.6 %	1.00
DMCC Speciality Chemicals Ltd	763 Cr.	306	453/241	35.4	91.1	0.33 %	14.6 %	9.87 %	10.0
Industry Average	12,913.36 Cr	814.08		47.08	179.72	0.38%	13.06%	25.68%	6.44

All Competitor Stocks of DMCC Speciality Chemicals Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	101.64	113.39	104.71	71.91	96.50	85.57	76.52	80.53	83.95	85.32	102.70	118.03	125.19
Expenses	90.45	98.49	101.11	70.83	80.21	74.60	66.99	73.41	76.55	76.47	87.40	100.29	110.07
Operating Profit	11.19	14.90	3.60	1.08	16.29	10.97	9.53	7.12	7.40	8.85	15.30	17.74	15.12
OPM %	11.01%	13.14%	3.44%	1.50%	16.88%	12.82%	12.45%	8.84%	8.81%	10.37%	14.90%	15.03%	12.08%
Other Income	3.10	0.72	0.40	0.91	0.77	0.88	0.81	0.67	9.29	0.21	0.31	0.39	0.44
Interest	2.46	2.29	1.84	3.16	3.29	3.47	2.88	3.56	3.85	3.01	2.77	2.53	2.19
Depreciation	2.62	3.32	4.92	4.80	4.54	3.55	3.90	3.91	4.33	4.16	4.25	4.25	4.03
Profit before tax	9.21	10.01	-2.76	-5.97	9.23	4.83	3.56	0.32	8.51	1.89	8.59	11.35	9.34
Tax %	59.50%	37.96%	0.00%	-45.23%	27.63%	34.99%	33.71%	6.25%	32.20%	26.46%	32.36%	30.57%	30.73%
Net Profit	3.73	6.22	-2.77	-3.28	6.68	3.14	2.36	0.29	5.78	1.39	5.80	7.88	6.47
EPS in Rs	1.50	2.49	-1.11	-1.32	2.68	1.26	0.95	0.12	2.32	0.56	2.33	3.16	2.59

Last Updated: May 31, 2025, 6:16 am

Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 125.19 Cr.. The value appears strong and on an upward trend. It has increased from 118.03 Cr. (Dec 2024) to 125.19 Cr., marking an increase of 7.16 Cr..
For Expenses, as of Mar 2025, the value is 110.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.29 Cr. (Dec 2024) to 110.07 Cr., marking an increase of 9.78 Cr..
For Operating Profit, as of Mar 2025, the value is 15.12 Cr.. The value appears to be declining and may need further review. It has decreased from 17.74 Cr. (Dec 2024) to 15.12 Cr., marking a decrease of 2.62 Cr..
For OPM %, as of Mar 2025, the value is 12.08%. The value appears to be declining and may need further review. It has decreased from 15.03% (Dec 2024) to 12.08%, marking a decrease of 2.95%.
For Other Income, as of Mar 2025, the value is 0.44 Cr.. The value appears strong and on an upward trend. It has increased from 0.39 Cr. (Dec 2024) to 0.44 Cr., marking an increase of 0.05 Cr..
For Interest, as of Mar 2025, the value is 2.19 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.53 Cr. (Dec 2024) to 2.19 Cr., marking a decrease of 0.34 Cr..
For Depreciation, as of Mar 2025, the value is 4.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.25 Cr. (Dec 2024) to 4.03 Cr., marking a decrease of 0.22 Cr..
For Profit before tax, as of Mar 2025, the value is 9.34 Cr.. The value appears to be declining and may need further review. It has decreased from 11.35 Cr. (Dec 2024) to 9.34 Cr., marking a decrease of 2.01 Cr..
For Tax %, as of Mar 2025, the value is 30.73%. The value appears to be increasing, which may not be favorable. It has increased from 30.57% (Dec 2024) to 30.73%, marking an increase of 0.16%.
For Net Profit, as of Mar 2025, the value is 6.47 Cr.. The value appears to be declining and may need further review. It has decreased from 7.88 Cr. (Dec 2024) to 6.47 Cr., marking a decrease of 1.41 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.59. The value appears to be declining and may need further review. It has decreased from 3.16 (Dec 2024) to 2.59, marking a decrease of 0.57.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:47 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	101	120	108	175	178	227	188	200	326	387	328	431
Expenses	86	101	91	145	155	174	160	165	286	351	292	374
Operating Profit	15	20	16	30	23	53	28	36	41	36	36	57
OPM %	15%	16%	15%	17%	13%	24%	15%	18%	12%	9%	11%	13%
Other Income	6	-1	0	1	1	1	6	8	6	3	10	1
Interest	2	2	1	5	4	3	2	2	5	11	14	10
Depreciation	3	2	2	4	4	5	6	7	8	18	16	17
Profit before tax	16	14	13	21	16	47	26	34	34	10	17	31
Tax %	0%	0%	9%	21%	21%	2%	-22%	4%	37%	35%	33%	31%
Net Profit	16	14	12	17	12	46	31	33	21	7	12	22
EPS in Rs	7.55	6.58	5.63	7.79	4.92	18.47	12.63	13.06	8.56	2.75	4.64	8.64
Dividend Payout %	0%	0%	0%	0%	10%	8%	0%	15%	6%	0%	22%	29%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-12.50%	-14.29%	41.67%	-29.41%	283.33%	-32.61%	6.45%	-36.36%	-66.67%	71.43%	83.33%
Change in YoY Net Profit Growth (%)	0.00%	-1.79%	55.95%	-71.08%	312.75%	-315.94%	39.06%	-42.82%	-30.30%	138.10%	11.90%

DMCC Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	14%
5 Years:	18%
3 Years:	10%
TTM:	32%

Compounded Profit Growth
10 Years:	3%
5 Years:	-7%
3 Years:	1%
TTM:	266%

Stock Price CAGR
10 Years:	19%
5 Years:	19%
3 Years:	-6%
1 Year:	5%

Return on Equity
10 Years:	16%
5 Years:	9%
3 Years:	5%
Last Year:	10%

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:25 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	21	21	21	25	25	25	25	25	25	25	25	25
Reserves	-13	1	13	35	48	91	120	148	168	173	184	202
Borrowings	38	35	27	30	25	22	25	35	93	101	88	47
Other Liabilities	53	32	34	59	59	51	42	55	97	101	80	106
Total Liabilities	99	88	94	149	156	188	212	263	383	400	377	380
Fixed Assets	26	24	26	83	87	99	101	108	174	230	238	234
CWIP	1	1	5	3	3	1	9	38	63	11	6	0
Investments	0	0	0	2	4	3	3	1	1	1	1	1
Other Assets	72	63	63	60	62	86	98	116	146	159	132	145
Total Assets	99	88	94	149	156	188	212	263	383	400	377	380

Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
For Reserves, as of Mar 2025, the value is 202.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Mar 2024) to 202.00 Cr., marking an increase of 18.00 Cr..
For Borrowings, as of Mar 2025, the value is 47.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 88.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 41.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 26.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 234.00 Cr.. The value appears to be declining and may need further review. It has decreased from 238.00 Cr. (Mar 2024) to 234.00 Cr., marking a decrease of 4.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 6.00 Cr..
For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
For Other Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Mar 2024) to 145.00 Cr., marking an increase of 13.00 Cr..
For Total Assets, as of Mar 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..

Notably, the Reserves (202.00 Cr.) exceed the Borrowings (47.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	13	22	17	29	18	21	27	32	51	30	38	38
Cash from Investing Activity +	11	-1	-7	-8	-9	-13	-17	-40	-98	-21	-10	-7
Cash from Financing Activity +	-24	-19	-10	-19	-9	-8	-6	3	45	-10	-27	-30
Net Cash Flow	0	2	1	2	0	-0	5	-4	-2	-1	1	2

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-23.00	-15.00	-11.00	0.00	-2.00	31.00	3.00	1.00	-52.00	-65.00	-52.00	10.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	50	61	44	44	45	45	48	48	58	56	49	51
Inventory Days	42	52	62	104	60	73	80	113	151	79	78	81
Days Payable	136	126	76	115	129	114	79	68	116	131	121	119
Cash Conversion Cycle	-45	-12	29	33	-25	4	49	93	94	3	6	13
Working Capital Days	4	15	1	-7	-15	-6	46	81	47	15	15	13
ROCE %	-1%	34%	34%	24%	35%	21%	43%	18%	19%	16%	7%	8%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	53.84%	53.84%	53.85%	53.84%	53.84%	53.84%	53.84%	53.84%	53.84%	53.84%	53.84%	53.84%
FIIs	0.03%	0.00%	0.06%	0.10%	0.05%	0.00%	0.00%	0.00%	0.00%	0.06%	0.26%	0.36%
DIIs	1.24%	1.25%	1.24%	1.24%	1.24%	1.24%	1.24%	1.26%	1.24%	1.24%	1.24%	1.24%
Public	44.89%	44.91%	44.84%	44.82%	44.85%	44.90%	44.91%	44.90%	44.91%	44.85%	44.66%	44.55%
No. of Shareholders	21,455	22,553	22,663	22,255	21,595	22,322	21,771	21,396	20,579	20,732	20,826	20,899

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	8.63	4.65	2.78	8.56	13.06
Diluted EPS (Rs.)	8.63	4.65	2.78	8.56	13.06
Cash EPS (Rs.)	15.34	10.95	9.84	11.79	15.80
Book Value[Excl.RevalReserv]/Share (Rs.)	91.25	84.02	79.49	77.64	69.44
Book Value[Incl.RevalReserv]/Share (Rs.)	91.25	84.02	79.49	77.64	69.44
Revenue From Operations / Share (Rs.)	172.93	131.50	154.26	130.83	80.25
PBDIT / Share (Rs.)	23.40	18.73	15.55	18.48	17.35
PBIT / Share (Rs.)	16.70	12.43	8.49	15.25	14.61
PBT / Share (Rs.)	12.48	6.92	4.25	13.69	13.65
Net Profit / Share (Rs.)	8.63	4.65	2.78	8.56	13.06
NP After MI And SOA / Share (Rs.)	8.63	4.65	2.78	8.56	13.06
PBDIT Margin (%)	13.53	14.24	10.07	14.12	21.61
PBIT Margin (%)	9.65	9.45	5.50	11.65	18.20
PBT Margin (%)	7.21	5.26	2.75	10.46	17.00
Net Profit Margin (%)	4.99	3.53	1.80	6.54	16.27
NP After MI And SOA Margin (%)	4.99	3.53	1.80	6.54	16.27
Return on Networth / Equity (%)	9.45	5.53	3.49	11.02	18.81
Return on Capital Employeed (%)	15.38	11.47	7.88	15.10	18.68
Return On Assets (%)	5.66	3.07	1.72	5.56	12.35
Long Term Debt / Equity (X)	0.17	0.27	0.34	0.28	0.09
Total Debt / Equity (X)	0.20	0.31	0.40	0.40	0.14
Asset Turnover Ratio (%)	1.14	0.84	0.98	1.01	0.84
Current Ratio (X)	1.23	1.08	1.04	0.95	1.68
Quick Ratio (X)	0.84	0.66	0.63	0.64	1.13
Inventory Turnover Ratio (X)	5.98	4.03	5.48	5.09	2.94
Dividend Payout Ratio (NP) (%)	0.00	0.00	35.98	5.84	11.68
Dividend Payout Ratio (CP) (%)	0.00	0.00	10.16	4.24	9.65
Earning Retention Ratio (%)	0.00	0.00	64.02	94.16	88.32
Cash Earning Retention Ratio (%)	0.00	0.00	89.84	95.76	90.35
Interest Coverage Ratio (X)	5.56	3.40	3.67	11.84	18.03
Interest Coverage Ratio (Post Tax) (X)	3.05	1.84	1.66	6.48	14.57
Enterprise Value (Cr.)	789.57	745.75	677.05	982.66	815.55
EV / Net Operating Revenue (X)	1.83	2.27	1.76	3.01	4.07
EV / EBITDA (X)	13.53	15.96	17.46	21.32	18.85
MarketCap / Net Operating Revenue (X)	1.74	2.09	1.56	2.78	3.96
Retention Ratios (%)	0.00	0.00	64.01	94.15	88.31
Price / BV (X)	3.29	3.27	3.02	4.69	4.58
Price / Net Operating Revenue (X)	1.74	2.09	1.56	2.78	3.96
EarningsYield	0.02	0.01	0.01	0.02	0.04

After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.98. This value is within the healthy range. It has increased from 4.03 (Mar 24) to 5.98, marking an increase of 1.95.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of DMCC Speciality Chemicals Ltd as of August 2, 2025 is: 255.48

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 2, 2025, DMCC Speciality Chemicals Ltd is Overvalued by 16.51% compared to the current share price 306.00

Intrinsic Value of DMCC Speciality Chemicals Ltd as of August 2, 2025 is: 235.22

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 2, 2025, DMCC Speciality Chemicals Ltd is Overvalued by 23.13% compared to the current share price 306.00

Last 5 Year EPS CAGR: -7.93%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 21.50%, which is a positive sign. The stock has a low average Working Capital Days of 17.42, which is a positive sign. The company has higher reserves (97.50 cr) compared to borrowings (47.17 cr), indicating strong financial stability. The company has shown consistent growth in sales (230.75 cr) and profit (23.25 cr) over the years.	The stock has a high average Cash Conversion Cycle of 20.17, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DMCC Speciality Chemicals Ltd:
1. Net Profit Margin: 4.99%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 15.38% (Industry Average ROCE: 13.06%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 9.45% (Industry Average ROE: 25.68%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.05
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.84
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 35.4 (Industry average Stock P/E: 47.08)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.2
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

DMCC Speciality Chemicals Ltd. is a Public Limited Listed company incorporated on 12/09/1919 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1919PLC000564 and registration number is 000564. Currently Company is involved in the business activities of Manufacture of other chemical products. Company's Total Operating Revenue is Rs. 431.23 Cr. and Equity Capital is Rs. 24.94 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	Prospect Chambers, 317/321, Dr. Dadabhoy Naoroji Road, Mumbai Maharashtra 400001	investors@dmcc.com http://www.dmcc.com

Management
Name	Position Held
Mr. Laxmikumar Narottam Goculdas	Chairman
Ms. Mitika Laxmikumar Goculdas	Vice Chairperson
Mr. Bimal Lalitsingh Goculdas	Managing Director & CEO
Mr. Kuldeep Kumar Tiwari	Executive Director - Operations
Mr. Mukul Manoharlal Taly	Ind. Non-Executive Director
Mr. Sanjeev Vishwanath Joshi	Ind. Non-Executive Director
Mr. Madhu Thakorlal Ankleshwaria	Ind. Non-Executive Director
Dr.(Mrs.) Janaki Ashwin Patwardhan	Ind. Non-Executive Director
Mr. Haren Devidas Parekh	Ind. Non-Executive Director

FAQ

What is the intrinsic value of DMCC Speciality Chemicals Ltd?

DMCC Speciality Chemicals Ltd's intrinsic value (as of 02 August 2025) is 255.48 16.51% lower the current market price of 306.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 763 Cr. market cap, FY2025-2026 high/low of 453/241, reserves of 202 Cr, and liabilities of 380 Cr.

What is the Market Cap of DMCC Speciality Chemicals Ltd?

The Market Cap of DMCC Speciality Chemicals Ltd is 763 Cr..

What is the current Stock Price of DMCC Speciality Chemicals Ltd as on 02 August 2025?

The current stock price of DMCC Speciality Chemicals Ltd as on 02 August 2025 is 306.

What is the High / Low of DMCC Speciality Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of DMCC Speciality Chemicals Ltd stocks is ₹453/241.

What is the Stock P/E of DMCC Speciality Chemicals Ltd?

The Stock P/E of DMCC Speciality Chemicals Ltd is 35.4.

What is the Book Value of DMCC Speciality Chemicals Ltd?

The Book Value of DMCC Speciality Chemicals Ltd is 91.1.

What is the Dividend Yield of DMCC Speciality Chemicals Ltd?

The Dividend Yield of DMCC Speciality Chemicals Ltd is 0.33 %.

What is the ROCE of DMCC Speciality Chemicals Ltd?

The ROCE of DMCC Speciality Chemicals Ltd is 14.6 %.

What is the ROE of DMCC Speciality Chemicals Ltd?

The ROE of DMCC Speciality Chemicals Ltd is 9.87 %.

What is the Face Value of DMCC Speciality Chemicals Ltd?

The Face Value of DMCC Speciality Chemicals Ltd is 10.0.